Antibioticoterapia para el paciente ambulatorio
Sussmann, Otto.
Trib. méd. (Bogotá)
; 98(3): 161-74, sept. 1998.
Artigo em Espanhol | LILACS | ID: lil-294114
Documentos relacionados
An antibiotic from an uncultured bacterium binds to an immutable target.
Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases.
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardship.
Efflux-linked accelerated evolution of antibiotic resistance at a population edge.
Environmental conditions define the energetics of bacterial dormancy and its antibiotic susceptibility.
Sensitive bacterial V<sub>m</sub> sensors revealed the excitability of bacterial V<sub>m</sub> and its role in antibiotic tolerance.
Systematic design of pulse dosing to eradicate persister bacteria.
Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> Catalyzed Three-Component Synthesis and Anti-Bacterial Activity of 3-Methyl-4-(hetero)arylmethylene isoxazole-5(4H)-ones.